FDA Announces Recall of Blood Pressure Medication

Comments (0)

The FDA has recently announced a voluntary recall of a widely prescribed blood pressure medication that is made in China. The drug is called valsartan.

Three companies sell the generic drug in the U.S. The FDA found that it may be tainted by N-nitrosodimethylamine (NDMA), which is considered a probable human carcinogen. The contamination is believed to be related to changes in the way that valsartan was manufactured.

All of the valsartan that is being recalled was made in China by Zhejiang Huahai Pharmaceutical Co. Ltd. The three companies that sell the drug in the U.S. are Major Pharmaceuticals, Teva Pharmaceutical Industries, and Solco Healthcare. The FDA recommends that patients who are taking the drug look at the manufacturer’s name on the label to determine if it is being recalled. If patients cannot tell, they should contact the pharmacy.

Patients who are taking valsartan should continue taking it until they have a substitute, which their doctor should be able to offer. There are other companies that market the drug that are not subject to the recall. According to experts, this is a very large recall, but there are other options for patients.

This recall has revived a debate about the safety of imported drugs. Companies that import drugs from other countries have a duty to ensure that those products are safe. If you have been harmed by a defective drug, you may wish to speak with an attorney. Call the Houston drug recall attorneys at Kennedy Hodges at 855-947-0707. We can help. Call today to learn more or to schedule a free consultation on your case.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.